Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19.

Quan Zhang Zhan YeAntonia BignottiX Long Zheng

Published in: Journal of clinical medicine (2023)

Endotheliopathy, marked by glycocalyx degradation and elevated plasma syndecan-1, occurs in nearly all hospitalized patients with SARS-CoV-2 infection; elevated plasma syndecan-1 is associated with increased mortality in COVID-19 patients.

Keyphrases

cardiovascular events
sars cov
risk factors
cardiovascular disease
coronary artery disease
clinical evaluation